Foreign body giant cells and osteoclasts are TRAP positive, have podosome-belts and both require OC-STAMP for cell fusion

Journal of Cellular Biochemistry

Volumn 114, Issue 8, 2013, Pages 1772-1778

  Khan, Usman A ^a   Hashimi, Saeed M ^a   Bakr, Mahmoud M ^a   Forwood, Mark R ^a   Morrison, Nigel A ^a  

^a GRIFFITH UNIVERSITY   (Australia)

Author keywords

DC STAMP; FBGC; MULTINUCLEAR GIANT CELLS; OC STAMP; OSTEOCLAST

Indexed keywords

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; F ACTIN; OSTEOCLAST STIMULATORY TRANSMEMBRANE PROTEIN; PROTEIN; PROTEIN ANTIBODY; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BONE MARROW; CELL CULTURE; CELL FUSION; CELL STRUCTURE; CONTROLLED STUDY; ENZYME INHIBITION; GIANT CELL; MONOCYTE; MOUSE; NONHUMAN; OSTEOCLAST; OSTEOLYSIS; PODOSOME; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION;

ACID PHOSPHATASE; ACTINS; ANIMALS; CELL FUSION; CELL MEMBRANE STRUCTURES; GENE EXPRESSION REGULATION; GIANT CELLS, FOREIGN-BODY; ISOENZYMES; MEMBRANE PROTEINS; MICE; OSTEOCLASTS; TIME FACTORS;

EID: 84879185027     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.24518     Document Type: Article

References (32)

1. Akisaka T, Yoshida H, Inoue S, Shimizu K,. 2001. Organization of cytoskeletal F-actin, G-actin, and gelsolin in the adhesion structures in cultured osteoclast. J Bone Miner Res 16: 1248-1255.
2. Akiyama T, Miyazaki T, Bouillet P, Nakamura K, Strasser A, Tanaka S,. 2005. In vitro and in vivo assays for osteoclast apoptosis. Biol Proced Online 7: 48-59.
3. Anazawa U, Hanaoka H, Morioka H, Morii T, Toyama Y,. 2004. Ultrastructural cytochemical and ultrastructural morphological differences between human multinucleated giant cells elicited by wear particles from hip prostheses and artificial ligaments at the knee. Ultrastruct Pathol 28: 353-359.
4. Anderson JM,. 1988. Inflammatory response to implants. ASAIO Trans 34: 101-107.
5. Bendixen AC, Shevde NK, Dienger KM, Willson TM, Funk CD, Pike JW,. 2001. IL-4 inhibits osteoclast formation through a direct action on osteoclast precursors via peroxisome proliferator-activated receptor gamma 1. Proc Natl Acad Sci USA 98: 2443-2448.
6. Boyle WJ, Simonet WS, Lacey DL,. 2003. Osteoclast differentiation and activation. Nature 423: 337-342.
7. Burstone MS,. 1959. Histochemical demonstration of acid phosphatase activity in osteoclasts. J Histochem Cytochem 7: 39-41.
8. Dai XM, Ryan GR, Hapel AJ, Dominguez MG, Russell RG, Kapp S, Sylvestre V, Stanley ER,. 2002. Targeted disruption of the mouse colony-stimulating factor 1 receptor gene results in osteopetrosis, mononuclear phagocyte deficiency, increased primitive progenitor cell frequencies, and reproductive defects. Blood 99: 111-120.
9. DeFife KM, Jenney CR, Colton E, Anderson JM,. 1999. Cytoskeletal and adhesive structural polarizations accompany IL-13-induced human macrophage fusion. J Histochem Cytochem 47: 65-74.
10. Destaing O, Block MR, Planus E, Albiges-Rizo C,. 2011. Invadosome regulation by adhesion signaling. Curr Opin Cell Biol 23: 597-606.
11. Dougall WC, Glaccum M, Charrier K, Rohrbach K, Brasel K, De Smedt T, Daro E, Smith J, Tometsko ME, Maliszewski CR, Armstrong A, Shen V, Bain S, Cosman D, Anderson D, Morrissey PJ, Peschon JJ, Schuh J,. 1999. RANK is essential for osteoclast and lymph node development. Genes Dev 13: 2412-2424.
12. Hattersley G, Owens J, Flanagan AM, Chambers TJ,. 1991. Macrophage colony stimulating factor (M-CSF) is essential for osteoclast formation in vitro. Biochem Biophys Res Commun 177: 526-531.
13. Hayman AR, Jones SJ, Boyde A, Foster D, Colledge WH, Carlton MB, Evans MJ, Cox TM,. 1996. Mice lacking tartrate-resistant acid phosphatase (Acp 5) have disrupted endochondral ossification and mild osteopetrosis. Development 122: 3151-3162.
14. Hodge JM, Kirkland MA, Aitken CJ, Waugh CM, Myers DE, Lopez CM, Adams BE, Nicholson GC,. 2004. Osteoclastic potential of human CFU-GM: Biphasic effect of GM-CSF. J Bone Miner Res 19: 190-199.
15. Hu S, Planus E, Georgess D, Place C, Wang X, Albiges-Rizo C, Jurdic P, Geminard JC,. 2011. Podosome rings generate forces that drive saltatory osteoclast migration. Mol Biol Cell 22: 3120-3126.
16. Jones KS,. 2008. Effects of biomaterial-induced inflammation on fibrosis and rejection. Semin Immunol 20: 130-136.
17. Jurdic P, Saltel F, Chabadel A, Destaing O,. 2006. Podosome and sealing zone: Specificity of the osteoclast model. Eur J Cell Biol 85: 195-202.
18. Keiler AM, Zierau O, Vollmer G, Scharnweber D, Bernhardt R,. 2012. Estimation of an early meaningful time point of bone parameter changes in application to an osteoporotic rat model with in vivo microcomputed tomography measurements. Lab Anim 46: 237-244.
19. Kim MS, Day CJ, Morrison NA,. 2005. MCP-1 is induced by receptor activator of nuclear factor-{kappa}B ligand, promotes human osteoclast fusion, and rescues granulocyte macrophage colony-stimulating factor suppression of osteoclast formation. J Biol Chem 280: 16163-16169.
20. Kim M, Park M, Baek S-H, Kim H, Kim S,. 2011. Molecules and signaling pathways involved in the expression of OC-STAMP during osteoclastogenesis. Amino Acids 40: 1447-1459.
21. Konttinen YT, Lappalainen R, Laine P, Kitti U, Santavirta S, Teronen O,. 2006. Immunohistochemical evaluation of inflammatory mediators in failing implants. Int J Periodontics Restorative Dent 26: 135-141.
22. Kukita T, Wada N, Kukita A, Kakimoto T, Sandra F, Toh K, Nagata K, Iijima T, Horiuchi M, Matsusaki H, Hieshima K, Yoshie O, Nomiyama H,. 2004. RANKL-induced DC-STAMP is essential for osteoclastogenesis. J Exp Med 200: 941-946.
23. McNally AK, Anderson JM,. 1995. Interleukin-4 induces foreign body giant cells from human monocytes/macrophages. Differential lymphokine regulation of macrophage fusion leads to morphological variants of multinucleated giant cells. Am J Pathol 147: 1487-1499.
24. Miyamoto H, Suzuki T, Miyauchi Y, Iwasaki R, Kobayashi T, Sato Y, Miyamoto K, Hoshi H, Hashimoto K, Yoshida S, Hao W, Mori T, Kanagawa H, Katsuyama E, Fujie A, Morioka H, Matsumoto M, Chiba K, Takeya M, Toyama Y, Miyamoto T,. 2012. OC-STAMP and DC-STAMP cooperatively modulate cell-cell fusion to form osteoclasts and foreign body giant cells. J Bone Miner Res 27: 1289-1297.
25. Moreno JL, Mikhailenko I, Tondravi MM, Keegan AD,. 2007. IL-4 promotes the formation of multinucleated giant cells from macrophage precursors by a STAT6-dependent, homotypic mechanism: Contribution of E-cadherin. J Leukoc Biol 82: 1542-1553.
26. Sobacchi C, Frattini A, Guerrini MM, Abinun M, Pangrazio A, Susani L, Bredius R, Mancini G, Cant A, Bishop N, Grabowski P, Del Fattore A, Messina C, Errigo G, Coxon FP, Scott DI, Teti A, Rogers MJ, Vezzoni P, Villa A, Helfrich MH,. 2007. Osteoclast-poor human osteopetrosis due to mutations in the gene encoding RANKL. Nat Genet 39: 960-962.
27. Ujihara M, Nomura K, Yamada O, Shibata N, Kobayashi M, Takano K,. 2001. Granulocyte-macrophage colony-stimulating factor ensures macrophage survival and generation of the superoxide anion: A study using a monocytic-differentiated HL60 subline. Free Radic Biol Med 31: 1396-1404.
28. Wu G, Hunziker EB, Zheng Y, Wismeijer D, Liu Y,. 2011. Functionalization of deproteinized bovine bone with a coating-incorporated depot of BMP-2 renders the material efficiently osteoinductive and suppresses foreign-body reactivity. Bone 49: 1323-1330.
29. Wulf E, Deboben A, Bautz FA, Faulstich H, Wieland T,. 1979. Fluorescent phallotoxin, a tool for the visualization of cellular actin. Proc Natl Acad Sci USA 76: 4498-4502.
30. Yagi M, Miyamoto T, Sawatani Y, Iwamoto K, Hosogane N, Fujita N, Morita K, Ninomiya K, Suzuki T, Miyamoto K, Oike Y, Takeya M, Toyama Y, Suda T,. 2005. DC-STAMP is essential for cell-cell fusion in osteoclasts and foreign body giant cells. J Exp Med 202: 345-351.
31. Yang M, Birnbaum MJ, MacKay CA, Mason-Savas A, Thompson B, Odgren PR,. 2008. Osteoclast stimulatory transmembrane protein (OC-STAMP), a novel protein induced by RANKL that promotes osteoclast differentiation. J Cell Physiol 215: 497-505.
32. Yu M, Moreno JL, Stains JP, Keegan AD,. 2009. Complex regulation of tartrate-resistant acid phosphatase (TRAP) expression by interleukin 4 (IL-4): IL-4 indirectly suppresses receptor activator of NF-kappaB ligand (RANKL)-mediated TRAP expression but modestly induces its expression directly. J Biol Chem 284: 32968-32979.